Greener and efficient processes: Quaternary Ammonium Salts
%20copy.png)
Quaternary Ammonium Salts play a crucial part in Organic Chemistry processes at many major industries. Discover why.
What are Quaternary Ammonium Salts (Quats)?
Dishman Carbogen Amcis Ltd. has rich expertise in Quaternary Ammonium Salts (Quats), and boasts an established, wide portfolio. But do you know exactly what Quats are, how and where they are used, and most importantly... why would you use them?
Quaternary Ammonium Salts (Quats) are a crucial part of organic chemistry processes across many major industries.
The quaternary ammonium cations are permanently charged, independent of the pH of their solution. Their permanent positive charge and hydrophilic carbon chains make Quats excellent Phase Transfer Catalysts. They are widely used in the productions of numerous products such as: Additives, Agrochemicals, Dyes, Pharmaceuticals, Paint & Coatings… and many more.
Due to their strong antimicrobial activity, they are also used in Disinfectants/Antiseptics. Other uses also include polymer modification, pollution treatment and the removal/destruction of impurities in wastes & product streams.
A wide range of reactions can make use of Quats as catalysts or reagents such as Etherification, Wittig reaction, Alkene synthesis, Borohydride Reduction and Chloromethylation… to name a few.
Diverse industries from Pharmaceuticals, Agrochemicals to Electronics are using Quats for the variety of their advantages.
Indeed, the use of Quats offers a number of benefits from an economic, environmental and quality-related point of view. These include:
- Easy and reliable up-scaling
- Low investments costs
- Elimination of expensive and dangerous reactants such as metal alkoxides
- Mild reaction conditions with increased process reliability
- Flexibility in solvent choice
- Minimization of industrial waste
- High yield and purity of the end
- Reduced reaction time
- Increased reaction rates that leads to enhanced selectivity
- Reduction of side products output
- Increased reactor volume efficiency
- Reduction or even elimination of the use of organic solvents
Therefore, Quats make many processes greener and more efficient by using less solvent, less energy & producing less harmful waste.
Contact Dishman Carbogen Amcis Ltd. to learn more about our established portfolio of Ammonium and Phosphonium Quats, and our extensive R&D capabilities.

Related News
-
News CPHI Americas 2025 - From the Floor
Our From the Floor live blog is back in Philadelphia for this year’s CPHI, this time under the new name CPHI Americas to embrace and represent the whole of the pharmaceutical supply chain from north to south.
-
News Women in Pharma: Unlocking patient inclusion at CPHI Americas
Our monthly Women in Pharma series highlights the influential lives and works of impactful women working across the pharmaceutical industry, and how the industry can towards making the healthcare industry and workplace more equitable and inclusive.&nbs... -
News Tracking Innovation with Thermo Fisher Scientific: CPHI Americas Track Sponsor interview
As we gear up for CPHI Americas from May 20-22, 2025 at the Philadelphia Convention Center, we sat down with Track Sponsor Thermo Fisher Scientific to discuss the future of bioproduction in pharma.
-
News Welcome back to the CPHI Exhibitor Spotlight!
We’re continuing our journey through the standout companies heading to CPHI Americas 2025, and next up is Adare - a global leader known for turning complex formulation challenges into innovative, patient-centric solutions.
-
News PhRMA trade association issues comments on Section 232 investigation
The Pharmaceutical Research and Manufacturers of America (PhRMA), an American trade association representing groups in the pharmaceutical industry, issued a letter on May 6, 2026 to the Department of Commerce regarding the Section 232 National Security... -
News Pharmaceutical Packaging Market Prospects: Shifting regional policies
The pharmaceutical packaging industry is experiencing significant transformation in 2025, driven by regulatory changes, supply chain challenges, and sustainability initiatives. The US BIOSECURE Act, passed through the House of Representatives in Septem... -
News Executive order to elevate US pharma manufacturing signed by Trump
On Monday, May 5, US President Trump signed an executive order to reduce regulatory barriers for domestic US pharmaceutical manufacturing, including key ingredients and materials for manufacturing prescription drugs.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.